Multidomain determinants of perivascular spaces indicate early cerebrovascular vulnerability in individuals at risk of Alzheimer’s disease
Authors:
- Alba Fernandez-BonetAFAlba Fernandez-Bonet
- Gerard Temprano-SagreraGTGerard Temprano-Sagrera
- Patricia GeniusPGPatricia Genius
- Blanca Rodriguez-FernandezBRBlanca Rodriguez-Fernandez
- Eugenia Domingo-GuellEDEugenia Domingo-Guell
- Jordi HuguetJHJordi Huguet
- Gonzalo Sanchez-BenavidesGSGonzalo Sanchez-Benavides
- Marleen de BruijneMBMarleen de Bruijne
Open Access
- 28 October 2026
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
Abstract
Background: Perivascular spaces (PVS) are MRI-visible markers of cerebrovascular and glymphatic function, but their regional determinants in preclinical Alzheimer’s disease (AD), regarding sex and AD biomarkers, remain poorly understood. Methods: We studied 1199 cognitively unimpaired ALFA study participants (aged 54–65 years), genetically enriched for AD risk, with CSF biomarker phenotyping in 296 participants. PVS were automatically quantified in basal ganglia, centrum semiovale, hippocampus, and midbrain on 3T MRI. Counts were modeled using Poisson or negative binomial regression, adjusting for demographics, cardiometabolic, lifestyle, and genetic factors, with effect modification by sex and amyloid/tau (AT) status. Results: PVS showed marked regional specificity. Centrum semiovale PVS were associated with age, male sex, and cardiometabolic factors, whereas hippocampal and midbrain PVS were more closely related to AD biomarker status and sleep or psychological measures. Men exhibited higher centrum semiovale burden while women showed higher counts in hippocampus, midbrain, and basal ganglia. Associations were stronger in amyloid-positive individuals with concurrent tau pathology. Polygenic scores for lipid and metabolic traits contributed modestly to regional PVS variation. Conclusions: PVS burden is associated with multidomain determinants in preclinical AD with regional, sex-specific, and biomarker-dependent patterns, supporting PVS as accessible MRI markers for risk stratification and precision prevention. “Early Identification of Markers in Alzheimer’s Families/ALFA (ALFA Cohort)” ( https://clinicaltrials.gov/study/NCT02485730 ). Registration number: NCT02485730.Keywords
Funding Information
- Instituto de Salud Carlos III (CP23/00039)
- Spanish Research Agency (PID2024-163071OB-I00)
- Alzheimer Association Research postdoctoral fellowship (25AARF-1377279)
- Alzheimer Nederland (WE.03-2024-07)
- Alzheimer’s Disease Data Initiative
- Dutch Research Council (2022.018)
- Ramón y Cajal fellowship (RYC2022-038136-I;PID2022-143106OA-I00)
- Alzheimer’s Association, AD Strategic Fund (Project #VCID-UMD-26-1514428)
- European Union
This publication has 75 references indexed in Scilit:
- Genetic characterization of the ALFA study: Uncovering genetic profiles in the Alzheimer's continuumAlzheimer's & Dementia, 2023
- Perivascular spaces as a marker of psychological trauma in depression: A 7‐Tesla MRI studyBrain and Behavior, 2022
- Perivascular spaces and brain waste clearance systems: relevance for neurodegenerative and cerebrovascular pathologyNeuroradiology, 2021
- Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuumAlzheimer's & Dementia, 2020
- Understanding the impact of sex and gender in Alzheimer's disease: A call to actionAlzheimer's & Dementia, 2018
- Role of Estrogens in the Regulation of Liver Lipid Metabolism2017
- The Cellular Phase of Alzheimer’s DiseaseCell, 2016
- The Glymphatic System: A Beginner’s GuideNeurochemical Research, 2015
- Sex modifies the APOE‐related risk of developing Alzheimer diseaseAnnals of Neurology, 2014
- Development of NO2 and NOx land use regression models for estimating air pollution exposure in 36 study areas in Europe – The ESCAPE projectAtmospheric Environment, 2013